Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome

Blood

Volumn 119, Issue 10, 2012, Pages 2239-2241

  Barbui, Tiziano ^a   Thiele, Jürgen ^b   Passamonti, Francesco ^c   Rumi, Elisa ^d   Boveri, Emanuela ^d   Randi, Maria Luigia ^e   Bertozzi, Irene ^e   Marino, Filippo ^e   Vannucchi, Alessandro M ^f   Pieri, Lisa ^f   Rotunno, Giada ^f   Gisslinger, Heinz ^g   Gisslinger, Bettina ^g   Müllauer, Leonhard ^g   Finazzi, Guido ^a   Carobbio, Alessandra ^a   Gianatti, Andrea ^a   Ruggeri, Marco ^h   Nichele, Ilaria ^h   D'Amore, Emanuele ^h   Rambaldi, Alessandro ^a   Tefferi, Ayalew ⁱ   more..

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

^c OSPEDALE DI CIRCOLO   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h SAN BORTOLO HOSPITAL   (Italy)

ⁱ MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETICULIN;

ALLELE; ARTICLE; BONE MARROW BIOPSY; BONE MARROW RETICULIN FIBROSIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LEUKEMIA; MAJOR CLINICAL STUDY; MYELOFIBROSIS; OVERALL SURVIVAL; POLYCYTHEMIA VERA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SPLENOMEGALY; THROMBOSIS;

EID: 84858062280     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-393819     Document Type: Article

References (15)

1. Ellis JT, Peterson P, Geller SA, Rappaport H. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Semin Hematol. 1986; 23(2):144-155.
2. Georgii A, Buesche G, Kreft A. The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol. 1998;11(4):721-749. (Pubitemid 29452760)
3. Thiele J, Kvasnicka HM. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Histol Histopathol. 2005;20(1):317-328. (Pubitemid 40029008)
4. Ellis JT, Silver RT, Coleman M, Geller SA. The bone marrow in polycythemia vera. Semin Hematol. 1975;12(4):433-444.
5. Ellis JT, Peterson P. The bone marrow in polycythemia vera. Pathol Annu. 1979;14(pt 1):383-403.
6. Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andreasson B. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. Eur J Haematol. 2011;86(2):148-155.
7. Buhr T, Georgii A, Choritz H. Myelofibrosis in chronic myeloproliferative disorders: incidence among subtypes according to the Hannover Classification. Pathol Res Pract. 1993;189(2):121-132. (Pubitemid 23123616)
8. Georgii A, Buhr T, Buesche G, Kreft A, Choritz H. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma. 1996; 22(suppl 1):15-29. (Pubitemid 26388528)
9. Thiele J, Kvasnicka HM, Fischer R. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders: aids to diagnosis and classification. Ann Hematol. 1999; 78(11):495-506.
10. Thiele J, Kvasnicka HM, Orazi A, Tefferi A, Birgegard G. Polycythemia vera. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:40-43.
11. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica. 2005;90(8):1128-1132. (Pubitemid 41323513)
12. Passamonti F, Rumi E, Pietra D, et al. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. Leukemia. 2010;24(24):1574-1579.
13. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood. 2002;100(13): 4272-4290. (Pubitemid 35429665)
14. Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110(4):1092-1097. (Pubitemid 47281402)
15. Thiele J, Kvasnicka HM. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis? Curr Hematol Malig Rep. 2006; 1(2):87-92. (Pubitemid 44623870)